AnaptysBio (NASDAQ:ANAB) – AnaptysBio Sells Royalty Interest in Cancer…
AnaptysBio Inc ANABa clinical-stage biotechnology company focused on immunological therapeutics has sold its interest in future global net sales of Zejula (niraparib) to a wholly